Everything You Need to Know About Asthma pathophysiology & treatment for Step 1

Asthma is one of those Step 1 “looks simple but tests deep” topics: you’re expected to recognize classic symptoms and understand the immunology, physiology, and pharmacology well enough to predict PFT changes, triggers, and side effects of therapy. If you can explain why asthma is reversible, why eosinophils matter, and why beta-agonists can cause tremor, you’re in great shape.

---

Where Asthma Fits: Obstructive Lung Disease (Pulmonary)

Asthma is an obstructive lung disease characterized by episodic, reversible airflow obstruction due to airway hyperresponsiveness and inflammation.

First Aid cross-reference (Pulmonary): Obstructive lung diseases; asthma pathogenesis; PFT patterns; asthma drugs (β₂-agonists, corticosteroids, leukotriene modifiers).

---

Definition (What the USMLE Means by “Asthma”)

Asthma = chronic inflammatory disorder of the airways leading to:

• Hyperresponsiveness (airways overreact to stimuli)
• Bronchoconstriction
• Increased mucus production
• Airway edema
• Airway remodeling over time (in some patients)

Key Step phrasing: reversible airway obstruction (vs COPD = less reversible).

---

Pathophysiology: The High-Yield Mechanism (Type I Hypersensitivity)

The “Sensitization → Re-exposure” Framework

Asthma (especially atopic asthma) is classically a Type I hypersensitivity reaction:

1. Initial exposure to allergen

   • Th2 response → IL-4, IL-5, IL-13
   • IL-4: class switching to IgE
   • IgE binds mast cells (sensitization)

2. Re-exposure

   • Allergen cross-links IgE on mast cells → degranulation → bronchoconstriction

Early vs Late Phase (Test Favorite)

Leukotrienes (LTC₄, LTD₄, LTE₄) are especially important for:

• Bronchoconstriction
• Increased vascular permeability (edema)
• Increased mucus secretion

Cytokines to Memorize (Step 1 core)

• IL-4 → IgE class switching
• IL-5 → eosinophil activation
• IL-13 → mucus production + airway hyperresponsiveness

Airway Remodeling (Why Chronic Asthma Gets Harder)

Long-standing inflammation can cause structural changes:

• Subepithelial fibrosis (thickened basement membrane)
• Smooth muscle hypertrophy/hyperplasia
• Mucus gland hyperplasia
• Increased vascularity

This is the “asthma can become less reversible over time” nuance that shows up in more integrative questions.

---

Classic Histology Findings (Often Tested with Images)

• Curschmann spirals: shed epithelial cells in mucus plugs
• Charcot–Leyden crystals: eosinophil-derived crystals (major basic protein)

First Aid cross-reference (Pathology/Pulm): Charcot-Leyden crystals, Curschmann spirals.

---

Clinical Presentation (How It Shows Up in Vignettes)

Classic symptoms

• Episodic wheezing
• Cough (often worse at night)
• Chest tightness
• Shortness of breath
• Symptoms often triggered by exposures and improve with bronchodilator

Common triggers (Step-relevant)

• Allergens (atopy)
• Viral URIs (common in kids)
• Exercise (exercise-induced bronchoconstriction)
• Cold air
• Occupational exposures
• Aspirin/NSAIDs (see AERD below)
• Beta-blockers (especially nonselective)

Physical exam clues

• Diffuse expiratory wheezes
• Prolonged expiratory phase
• If severe: decreased breath sounds (“silent chest”) = impending respiratory failure

---

Diagnosis (PFT Pattern + Reversibility)

Obstructive pattern basics

Asthma is obstructive → hard to get air out:

• ↓ FEV₁
• ↓ FEV₁/FVC
• Often ↑ TLC and ↑ RV due to air trapping (especially during exacerbations)

Reversibility criterion (high yield)

Spirometry shows obstruction that improves after bronchodilator:

• Increase in FEV₁ by ≥ 12% and ≥ 200 mL after inhaled β₂-agonist (commonly taught threshold)

Methacholine challenge (when spirometry is normal but suspicion is high)

• Methacholine is a muscarinic agonist → induces bronchoconstriction
• Positive test: decrease in FEV₁ at low doses (hyperresponsive airways)

Interpretation pearl:

• High sensitivity → a negative test helps rule out asthma in many contexts.

First Aid cross-reference (Pulm Phys): PFT obstructive patterns; methacholine challenge.

---

Step-Style Differentials (Don’t Get Tricked)

Asthma vs COPD (quick compare)

Asthma vs Vocal Cord Dysfunction

• VCD: often inspiratory stridor, throat tightness, poor response to bronchodilators; flow-volume loop may show variable extrathoracic obstruction.

Acute severe asthma vs anaphylaxis

• Anaphylaxis adds: hypotension, urticaria, GI symptoms; treat with IM epinephrine.

---

Treatment: The USMLE Medication Map

Big picture: rescue vs controller

• Rescue (quick relief): inhaled short-acting β₂-agonist (SABA) like albuterol
• Controller (long-term): reduce inflammation (especially inhaled corticosteroids)

Stepwise therapy (conceptual, not guideline minutiae)

USMLE loves the principle: ICS are first-line controller therapy for persistent asthma.

---

Drug Deep Dive (Mechanisms + Side Effects + Buzzwords)

β₂-agonists

Examples: albuterol (SABA), salmeterol/formoterol (LABA)

Mechanism: β₂ stimulation → ↑ cAMP in smooth muscle → bronchodilation

Key adverse effects (adrenergic):

• Tremor
• Tachycardia/palpitations
• Possible hypokalemia (β₂ drives K⁺ into cells)

High-yield warning:

• LABA should not be used as monotherapy in asthma (use with ICS) due to increased risk of asthma-related death in uncontrolled disease.

First Aid cross-reference (Pharm): β₂-agonists MOA and adverse effects.

---

Inhaled corticosteroids (ICS)

Examples: budesonide, fluticasone

Mechanism: anti-inflammatory; downregulate cytokines, decrease eosinophils, reduce mucosal edema and mucus

Adverse effects (local):

• Oral candidiasis (thrush)
• Dysphonia Prevention: rinse mouth after use, use spacer.

Systemic effects are more likely with high-dose or oral steroids: adrenal suppression, osteoporosis, hyperglycemia, etc.

---

Leukotriene pathway modifiers (very testable)

Montelukast, zafirlukast: block CysLT1 receptors (LTC₄/LTD₄/LTE₄)
Zileuton: inhibits 5-lipoxygenase → ↓ leukotriene synthesis

Best clinical associations:

• Aspirin-exacerbated respiratory disease (AERD)
• Exercise-induced asthma
• Allergic rhinitis adjunct

Adverse effects:

• Zileuton: hepatotoxicity (watch LFTs)
• Montelukast: classically associated with neuropsychiatric effects (Step may mention mood changes)

First Aid cross-reference: leukotriene modifiers; aspirin asthma.

---

Antimuscarinics (especially in acute settings)

Examples: ipratropium (SAMA), tiotropium (LAMA)

Mechanism: block M3 → ↓ bronchoconstriction

Use:

• Often added in acute exacerbations (ipratropium) along with SABA
• Tiotropium can be add-on controller in some patients

Adverse effects:

• Dry mouth, urinary retention (anticholinergic effects)

---

Methylxanthines (less common, still board-relevant)

Theophylline

Mechanism: inhibits phosphodiesterase → ↑ cAMP; adenosine receptor antagonism

Toxicity mnemonic: “Theophylline causes 3 Ds”

• Drugs (many interactions; CYP metabolism)
• Dysrhythmias
• Death/Seizures (CNS stimulation)

---

Acute Asthma Exacerbation (Step 2-style, but Step 1 mechanisms matter)

Core acute management:

• Inhaled SABA (albuterol)
• Systemic corticosteroids (e.g., prednisone, methylprednisolone) to reduce inflammation (not instant, but crucial)
• Oxygen as needed
• Add ipratropium for moderate/severe exacerbations

Escalation for severe/life-threatening:

• IV magnesium sulfate (smooth muscle relaxation) in severe cases
• Consider intubation/ventilation if impending respiratory failure

High-yield red flags for impending failure:

• Rising $PaCO_2$ (fatigue; “normalizing CO₂” can be bad)
• Silent chest, altered mental status
• Hypoxemia despite oxygen

---

Key High-Yield Associations & Classic Vignette Traps

1) Aspirin-Exacerbated Respiratory Disease (AERD)

Triad:

• Asthma
• Nasal polyps
• Aspirin sensitivity

Mechanism:

• COX inhibition shunts arachidonic acid toward leukotriene production → bronchospasm.

Treatment tie-in:

• Leukotriene receptor blockers (montelukast) or 5-LO inhibitor (zileuton) can help.

2) Atopy package deal

Asthma commonly coexists with:

• Allergic rhinitis
• Eczema (atopic dermatitis)

Think “Th2/eosinophils/IgE” across these.

3) Status asthmaticus physiology pearl

Air trapping → dynamic hyperinflation → increased work of breathing → fatigue.
In severe obstruction, wheezing may disappear (silent chest) because airflow is minimal.

---

Rapid Review Table (What to Recall in 30 Seconds)

---

First Aid Cross-Reference Checklist (Quick Study Guide)

When you review First Aid, make sure you can connect asthma to:

• Obstructive lung disease PFT patterns (FEV₁/FVC ↓)
• Type I hypersensitivity and Th2 cytokines
• Eosinophils and their histologic clues
• Asthma pharmacology: β₂-agonists, ICS, leukotriene modifiers, theophylline, antimuscarinics
• Aspirin-induced asthma/nasal polyps association

---

Final Exam Tip: “What’s the Test Writer Actually Asking?”

Most asthma questions are secretly one of these:

1. Identify reversible obstruction (spirometry + bronchodilator response)
2. Recognize Type I hypersensitivity (IgE, mast cells, eosinophils)
3. Pick the right med class (SABA rescue, ICS controller, leukotriene mods for aspirin/exercise-related)
4. Spot danger signs in an acute exacerbation (silent chest, rising CO₂)

If you can do those four reliably, asthma becomes free points.